As you will soon discover, medical science is finally beginning to make those crucial breakthroughs in the understanding and potential treatment of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS — among others.
A cure for these and other brain disorders may be just around the corner!
I hope the company comes through with a new PD drug (which actually works) to relieve symptoms. I did a little research and found a study which investigated whether Bacoside-1, a component of the herb, Bacopa monnieri, interacts with DJ-1:
My day job is investments, specializing in biotechnology. The steps for bringing a new drug to market are preclinical (cell culture studies then animals)->phase 1 (human safety & dosing) -> phase 2 (proof of concept in uncontrolled studies) -> phase 3 (controlled studies) -> New Drug Application -> FDA Advisory committee review -> FDA approval decision. This process takes many years and costs $10s - $100s of millions or even $billions depending on the drug. This company has all of $100k in cash which apparently was a loan from insiders cause they owe insiders $188k. See:
They have *not* even identified a candidate drug yet*, much less tested it in any preclinical model - so they have *not* even gotten to the *preclinical* stage. See:
I get stuff like "bioscience report" in the mail from time to time. These pieces are all the same - they never mention anything about company finances or stage of development - because there is *nothing* to see. Invariably these companies are listed on the "bulletin board" because they do not qualify for listing on an exchange. This is what is known in the business as a "pump and dump" - sucker uneducated investors into buying and leave them holding the bag.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Sinemet intake blocked by Proteins
Copper Leads to Protein Aggregation in Parkinson’s Disease
Vascular Dysfunction in the Brain as an Initiating Event in Parkinson’s Disease
Aspirin targets key protein in neurodegenerative diseases - updates? 
